Brian Druker

Board Director

Director

US·SEC (Form 4)

Amgen Inc

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 21 May 2026 for AMGEN INC. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Brian Druker: trading record in brief

Brian Druker (board member) discloses dealings in Amgen Inc to SEC (Form 4). Over a trading history stretching from 18 May 2021 to 19 May 2026, the count stands at 6 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 21 May 2026 came the latest disclosure, a share grant in Amgen Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.